Clinical Trials Browser

Interventional × Triple Negative Breast Neoplasms × Focus Groups × Clear all

NCT04118062 2025-09-19

Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR)

Phase NA Completed

BreastDermatologic

Uveal Melanoma, Neoplasms, Triple Negative Breast Neoplasms